Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation

The Journal of Pharmacology and Experimental Therapeutics
Elizabeth A VecchioLauren T May

Abstract

Aberrant ligand-independent G protein-coupled receptor constitutive activity has been implicated in the pathophysiology of a number of cancers. The adenosine A2B receptor (A2BAR) is dynamically upregulated under pathologic conditions associated with a hypoxic microenvironment, including solid tumors. This, in turn, may amplify ligand-independent A2BAR signal transduction. The contribution of A2BAR constitutive activity to disease progression is currently unknown yet of fundamental importance, as the preferred therapeutic modality for drugs designed to reduce A2BAR constitutive activity would be inverse agonism as opposed to neutral antagonism. The current study investigated A2BAR constitutive activity in a heterologous expression system and a native 22Rv1 human prostate cancer cell line exposed to hypoxic conditions (2% O2). The A2BAR inverse agonists, ZM241385 [4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol] or PSB-603 (8-(4-(4-(4-chlorophenyl)piperazide-1-sulfonyl)phenyl)-1-propylxanthine), mediated a concentration-dependent decrease in baseline cAMP levels in both cellular systems. Proliferation of multiple prostate cancer cell lines was also attenuated in the presence of PSB-603. Import...Continue Reading

References

Mar 1, 1995·Trends in Pharmacological Sciences·P Leff
Jan 19, 1995·The New England Journal of Medicine·P KoppG Vassart
Aug 1, 1993·Trends in Pharmacological Sciences·R J LefkowitzT Costa
Feb 1, 1997·Molecular Pharmacology·E S BursteinM R Brann
May 23, 2000·Critical Reviews in Biochemistry and Molecular Biology·G L Semenza
Oct 12, 2000·Acta Anaesthesiologica Scandinavica·H T Sommerschild, K A Kirkebøen
Feb 24, 2001·Trends in Pharmacological Sciences·G Milligan, A P Ijzerman
Feb 7, 2002·Trends in Pharmacological Sciences·Philip G Strange
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Oct 17, 2002·Naunyn-Schmiedeberg's Archives of Pharmacology·Roland Seifert, Katharina Wenzel-Seifert
Oct 31, 2002·Nature Reviews. Drug Discovery·Derek T Chalmers, Dominic P Behan
May 14, 2003·Clinical & Experimental Metastasis·Patrick Subarsky, Richard P Hill
Jan 13, 2006·Trends in Pharmacological Sciences·Richard A Bond, Ad P Ijzerman
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tianqing KongSean P Colgan
Feb 8, 2007·Current Opinion in Pharmacology·Sergio Parra, Richard A Bond
May 26, 2007·Molecular Pharmacology·Lauren T MayArthur Christopoulos
Aug 21, 2008·Neoplasia : an International Journal for Oncology Research·Sergey RyzhovIgor Feoktistov
Dec 17, 2008·Endocrine, Metabolic & Immune Disorders Drug Targets·J Ham, D A Rees
Sep 19, 2009·Trends in Pharmacological Sciences·Riccardo Polosa, Michael R Blackburn
Nov 26, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Caglar CekicJoel Linden
Oct 17, 2012·Laboratory Investigation; a Journal of Technical Methods and Pathology·Angel CárdenasRody San Martín
Jan 15, 2013·Purinergic Signalling·Qiang WeiKenneth A Jacobson
Feb 23, 2013·Molecular Pharmacology·Kirstie A BennettChristopher J Langmead
Jan 7, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tobias EckleHolger K Eltzschig
Jan 10, 2014·Neoplasia : an International Journal for Oncology Research·Raffaella IannoneSilvana Morello
Aug 1, 2015·BMC Cancer·Hiroki KasamaKatsuhiro Uzawa

❮ Previous
Next ❯

Citations

Sep 9, 2016·Frontiers in Chemistry·Ying Sun, Pingbo Huang
Oct 13, 2016·Life Sciences·Cesar SepúlvedaEduardo Fuentes
Dec 14, 2016·Journal of Medicinal Chemistry·Manuela JörgPeter J Scammells
Feb 25, 2017·Journal of Cellular Physiology·Mohammad H KazemiFarhad Jadidi-Niaragh
Oct 24, 2017·Nature Reviews. Cancer·Dipti VijayanMark J Smyth
Mar 4, 2018·HNO·P J SchulerT K Hoffmann
May 13, 2018·Purinergic Signalling·Sonja HinzChrista E Müller
Dec 6, 2018·International Journal of Molecular Sciences·Kevin SekPaul A Beavis
Jul 25, 2019·Current Pharmaceutical Design·Balakumar ChandrasekaranNikhil Agrawal
Nov 28, 2019·Experimental and Therapeutic Medicine·Jae Hyun KwonEunyoung Tak
Nov 20, 2019·International Journal of Molecular Sciences·Juliana Hofstätter AzambujaTheresa L Whiteside
May 1, 2020·Frontiers in Immunology·Jerry B HarveyJessica L Bowser
Oct 20, 2019·International Journal of Molecular Sciences·Zhan-Guo Gao, Kenneth A Jacobson
Dec 18, 2019·International Journal of Cancer. Journal International Du Cancer·Max WilkatCornelia Brunner
Mar 4, 2021·Journal of Chemical Information and Modeling·Sifan LyuJiangfeng Du
Oct 13, 2020·International Immunopharmacology·Jianrui ZengHuabao Xiong
Mar 6, 2019·Journal of Medicinal Chemistry·Jie JiangChrista E Müller
Jul 16, 2020·Journal of Medicinal Chemistry·Fazhi YuYonghui Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.